View Older Stories View More Recent Stories
-
X4 Pharmaceuticals Prices $65 Million Public Offering of Common Stock and Class B Warrants
-
SiTime Corporation Announces IPO Completion
-
SiTime Corporation Announces IPO Completion
-
X4 Pharmaceuticals (XFOR) to Offer Common Stock and Warrants
-
X4 Pharmaceuticals Announces Proposed Public Offering
-
ROTH Capital Partners and Sustain SoCal to Host Cleantech Private Capital Day v2 in Irvine, California on December 4, 2019
-
Roth Capital Reiterates Buy Rating on Charlotte's Web Holdings (CWEB:CN) (CWBHF)
-
Tesla shares rise as Musk says Cybertruck orders hit 200,000
-
Roth Capital Starts Vascular Biogenics Ltd (VBLT) at Buy
-
McEwen Mining Announces Closing of US$50 Million Public Offering
-
McEwen Mining Announces Closing of US$50 Million Public Offering
-
Arcimoto, Inc. (FUV) Prices 5M Public Offering of Common Stock at $1.80/Share
-
Arcimoto Announces Pricing of Public Offering of Common Stock
-
Roth Capital Starts Amplify Energy Corp. (AMPY) at Buy
-
SiTime Corp. (SITM) IPO Opens, Trades Higher
-
SiTime Corp. (SITM) Prices 4.3M Share IPO at $13/Sh
-
CRISPR Therapeutics (CRSP) Prices 4.25M Share Common Offering at $64.50/Sh
-
SiTime Corporation Announces Pricing of Initial Public Offering
-
SiTime Corporation Announces Pricing of Initial Public Offering
-
CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares
-
Mcewen Mining (MUX) Pricing of $50 Million Public Offering of Common Stock and Warrants
-
McEwen Mining Announces Pricing of US$50 Million Public Offering
-
McEwen Mining Announces Pricing of US$50 Million Public Offering
-
Mcewen Mining (MUX) Announces Proposed Common Share Offering
-
McEwen Mining Announces Proposed Public Offering
-
McEwen Mining Announces Proposed Public Offering
-
CRISPR Therapeutics (CRSP) PT Raised to $100 at Roth Capital
-
Lipocine Announces Closing Of Public Offering Of Common Stock And Warrants
-
Village Farms International (VFF) PT Lowered to $19 at Roth Capital
-
Intec Pharma Ltd. (NTEC) PT Lowered to $0.85 at Roth Capital
-
ShotSpotter (SSTI) PT Lowered to $33 at Roth Capital
-
Lipocine (LPCN) Prices 10.45M Class A Unit & 1.55M Class B Unit Offerings at $0.50/Unit
-
Lipocine Announces Pricing Of Public Offering Of Common Stock And Warrants
-
Amtech to Participate in ROTH Capital Partners SiC and GaN Day in New York
-
Replimune (REPL) Prices 3.678M Share Common Offering at $13.61/Sh
-
Replimune Announces Pricing of Public Offering
-
Replimune Announces Pricing of Public Offering
-
UPDATE: Roth Capital Downgrades Myomo Inc. (MYO) to Neutral
-
Roth Capital Starts Glycomimetics (GLYC) at Buy
-
Roth Capital Starts Bicycle Therapeutics (BCYC) at Buy
-
Roth Capital Starts Arvinas Inc. (ARVN) at Buy
-
Roth Capital Starts Turning Point Therapeutics Inc. (TPTX) at Buy
-
Roth Capital Starts Harpoon Therapeutics (HARP) at Buy
-
Lipocine (LPCN) Announces Launch of Public Offering of Common Stock, Warrants
-
Lipocine Announces Launch Of Public Offering Of Common Stock And Warrants
-
Pre-Open Movers 11/11: (CARB) (SPWR) (WBA) Higher; (LPCN) (NXTC) (FOMX) Lower (more...)
-
Roth Capital Downgrades Ormat Technologies (ORA) to Neutral
-
Roth Capital Upgrades Plug Power (PLUG) to Buy
-
The Eastern Company to Participate in ROTH Technology & New Industrials Day on November 13, 2019
-
Roth Capital Downgrades TPI Composites (TPIC) to Neutral

